Why Kazia Therapeutics (KZIA) Shares Are Plunging Today
[ad_1] Kazia Therapeutics Limited KZIA said GBM AGILE, a pivotal study for paxalisib in newly diagnosed glioblastoma, did not meet pre-defined criteria for continuing to a second stage. Patients enrolled in…